David L. Eigen


In 2015, David co-founded P5 Health Ventures to fulfill a twenty year old vision of consumer-driven personalized healthcare.

In 1999, David founded Post Road Capital Management (PRCM), an asset management firm that invests in public equities, private companies and alternative assets. David has significant experience in the healthcare, consumer, real estate, retail, insurance, and information technology industries. He has spent years working with management teams focusing on capital allocation and brand management.

From 2001 to 2009 in the Post Road Value Fund, David generated a 10% annualized return during a period when the S&P 500 generated negative returns; cumulatively outperforming the S&P 500 by over 110% and the Russell 2000 by over 80%. From 2005 until 2015, he also managed the Post Road Focused Fund and its successor entity, the PRy3 Fund.

From July 2009 until June 2011, David worked at Iridian Asset Management, a long-only institutional asset management firm, where he was a managing director and co-portfolio manager with direct supervision over $7.5 billion in assets.

In 1997, David started VitaSave, one of the first online marketplaces for discounted vitamin and food supplements and related materials. VitaSave was a pivot from the original project, an online integrative health forum for patients and practitioners dedicated to finding medical best practices. It was the unclear legal environment that led to the pivot. In late 1998, David sold VitaSave to a competitor and turned his focus to building PRCM.

David holds a B.S. in Economics from the Wharton School at the University of Pennsylvania and a J.D. from Benjamin Cardozo School of Law at Yeshiva University. He sits on the board of the Stillwater Insurance Company, a property and casualty insurer. He lives in Westport, CT with his wife and three sons. He enjoys coaching kids, qigong, trail running, crossfit, tennis, basketball, skiing and lacrosse. He co-manages a foundation dedicated to health and human services and is active in other charitable endeavors.

Harngid Cho


In May 2017, Harngid graduated from University of Pennsylvania’s School of Engineering and Applied Sciences with a Master of Biotechnology. Now a director, he first started working with P5 Health Ventures in January of 2017. Prior to P5HV, Harngid worked in investment banking at Morgan Stanley in the financial institutions group, where he analyzed managed care companies; he also worked at Monashee Investment Management, during which he covered healthcare investments in therapeutics, medical technology, and healthcare services. Previously, Harngid completed a Master of Finance from the MIT Sloan School of Management, and was the recipient of the Deans Fellowship, writing his masters thesis on healthcare finance. Prior to MIT, Harngid received an M.P.H. at Columbia University in healthcare management where he was the recipient of the Emerging Healthcare Leader of New York Distinction Scholarship. He graduated with distinction from the University of Michigan (B.S.), majoring in Brain Behavior Cognitive Science.

Charlotte Dequeker

Investor Relations

Charlotte joined Post Road Capital in 2012. For over eight years, she worked closely with Alain Ducasse in Monaco and Paris before moving to the United States in 2002. Over the next seven plus years, she worked for the jewelry designer, James De Givenchy. Charlotte graduated from Ecole Nouvelles in Nice, France, with a degree in Journalism and Communication. She lives in Greenwich, CT with her husband and three teenage sons. Charlotte is a past ironman finisher and current ultramarathoner, having completed multiple 50 and 100 mile races.

Office: 203-292-9267

Terry Fadem


Mr. Fadem currently serves as a Senior Fellow at the Mack Institute for Innovation Management at The Wharton School of Business. Terry Fadem is a founding board member of (BREF).  Mr. Fadem has a corporate background as the former director of new business development for The DuPont Corporation, working to develop and market medical devices, diagnostics and drugs. He most recently had oversight of all corporate sponsored research at The University Pennsylvania Medical School’s research center.  His current professional title is Senior Fellow at the Mack center for Managing Technological Innovation at the Wharton Business School where he focused on bridging the gap between science and the development of a business view of improving outcomes.

2008 – Present

  • Member NIH CTSA Public Private Partnership Oversight Committee

2003 – Present

  • Founder. BREF (Board President) Senior Fellow, Mack Institute for Innovation Management, Wharton Business School Managing Director, Office of Corporate Research, Perelman School of Medicine Member, Internal Advisory Board for the Penn Center for Orphan Diseases,
  • Board Member, Center for Evidence Based Medicine
  • Director, Commercialization And Entrepreneurship Program for the Institute for Therapeutics and Translational Medicine

2001 – 2003

  • Founder, virtualworkshops.com
  • Founder, Pradica Strategic Business Consulting

1981 – 2001

  • Technical Service Biochemist, the DuPont Company, Medical Diagnostics
  • Business Product Development, Medical Products, DuPont
  • Market Research Manager, DuPont Diagnostics
  • Manager, DuPont Diagnostics
  • Manager, DuPont Medical X-Ray
  • Biotechnology Business Director, DuPont Agricultural Products Director,
  • Strategic Planning, DuPont Corporate Plans
  • Director, Global New Business Development, DuPont

1979 – 1981

  • Foundation Scientific Director
  • National Committee for Clinical Laboratory Standards

1976 – 1979

  • Chairman, Quality Control Committee, Department of Laboratory Medicine, the Cleveland Clinic

Daniel Beiting, Ph.D.


Dr. Beiting completed his Ph.D. in Immunology at Cornell University, where his studies helped to elucidate the molecular mechanisms that regulate chronic inflammation.  Following his Ph.D., he completed postdoctoral training at the University of Pennsylvania, where he used cutting-edge genomic approaches and data mining to understand interactions between infectious diseases and the immune system – work supported by a National Research Service Award from the National Institutes of Health.

He is currently a Research Assistant Professor in Pathobiology at UPenn’s School of Veterinary Medicine where he continues to work at the intersection of immunology, microbiology and genomics, and helped to establish and direct the Center for Host-Microbial Interactions (CHMI).  Broadly speaking, CHMI’s mission is to better understand and treat disease through the study of microbes and microbial communities.  Through CHMI, he helps to fund research, train scientists, and forge collaborations within the scientific community at UPenn to advance research on diseases relevant to both human and animal health.  Dr. Beiting has authored 30 peer-reviewed publications, and his current research examines how the ‘microbiome’ – a complex ecosystem of microbes that lives in around around us all – can be used to better understand, diagnose and treat disease.


Brent Bauer, MD


Brent Bauer, MD, is a professor of medicine and is the founder of the Mayo Clinic Integrative Medicine Program.  He currently serves as the Research Director for the Integrative Medicine and Health Program.  Dr. Bauer’s personal goal is to bring real, evidence-based knowledge to patients and physicians trying to incorporate the best of conventional and complementary medicine practices.

Dr. Bauer’s core therapeutic areas include: mind-body applications, herbal and dietary supplements, acupuncture, and massage therapy.  His targeted patient populations include those with cancer, heart disease, gastrointestinal disorders, nicotine dependence, fatigue and fibromyalgia.


The research of Dr. Bauer and the Integrative Medicine and Health Program has had many tangible impacts on patient care.  For example, massage therapy is now routinely offered to Mayo Clinic postoperative patients, meditation training is being provided to more than 20,000 patients each year, and acupuncture is helping patients with migraine headaches. Research informing practice remains a key focus for the Integrative Medicine and Health Program.


  • Fellow (Advanced General Medicine), Mayo Graduate School of Medicine, Mayo Clinic College of Medicine
  • Resident, (Internal Medicine), Mayo Graduate School of Medicine, Mayo Clinic College of Medicine
  • MD, Mayo Medical School, Mayo Clinic College of Medicine
  • BA – summa cum laude, University of Minnesota, Twin Cities

Kathryn Schmitz, Ph.D.


Kathryn Schmitz, PhD, MPH, FACSM, is a professor of Epidemiology and Biostatistics at the University of Pennsylvania’s Perelman School of Medicine. She is an exercise interventionist who has led multiple trials, including a large randomized controlled trial to assess the safety of upper body exercise among 295 breast cancer survivors with and without lymphedema.  Her protocols for exercise in cancer care are already being used by several major institutions and practitioners.

Dr. Schmitz has over 180 peer reviewed scientific papers and has had continuous NIH funding for her research since 2001.  She served on the expert panel for the YMCA/Lance Armstrong Foundation Cancer Survivorship Collaborative, wrote the cancer survivorship section of the 2008 U.S. DHHS report of the Physical Activity Guidelines Advisory Committee, served on the ad hoc committee that developed the ACSM Cancer Exercise Trainer certification, and is the lead author of the 2010 ACSM Roundtable on Exercise for Cancer Survivors, which published guidance for exercise testing and prescription for cancer survivors. In 2010, the National Lymphedema Network awarded Dr. Schmitz the Catalyst Award, for being a researcher whose work has stimulated thought, discussion, and debate that leads to improvement in patient care for those with lymphedema.

Dr. Schmitz’ long term professional goal is to see that exercise is an integral part of all cancer control protocols as it already is today for heart disease.  Her research extends from the role of physical activity in the prevention and etiology of obesity related cancers to the usefulness of activity for rehabilitation and health promotion in cancer survivors of all cancers.

Her meta-analyses on the topic of exercise interventions in cancer patients and survivors, published in 2005 and 2010, provide a starting point for clinicians to understand the effects of exercise among cancer survivors.


  • BA (Economics), University of North Carolina, 1984.
  • MS Ed. (Exercise Physiology), Queens College, City University of New York, 1994.
  • Ph.D. (Kinesiology, Minor: Epidemiology ), University of Minnesota, 1998.
  • MPH (Epidemiology), University of Minnesota, 1999.

Kristi Clay, DC

After graduating from Fresno State University and graduating from Palmer Chiropractic College -West in 1992, Dr. Clay founded Samaritan Health Center, a multi-disciplinary health center, which incorporated Chiropractic, Nutrition, Chinese medicine, Acupuncture, Naturopathic medicine, Classical and German homeopathic medicine, Qigong, Tai chi, Yoga and meditation.

Dr. Clay held and maintained a CCN and DACBN in Nutrition for 20 years and continues to study and practice integrated and functional medicine. She lives with her husband and three children in Silicon Valley and is actively involved in educating her patients and the public about the nutritional needs of children and adults surviving cancer among other chronic ailments. Unlike many Western medical practitioners, she works to support each patient’s systems and has used this philosophy to successfully treat numerous patients over more than 20 years.

In 2004, Dr Clay supported her three-year-old son through three years of chemotherapy at Lucile Packard Children’s Hospital after a diagnosis of leukemia. Using her knowledge of nutrition and integrated medicine, her son was able to avoid opportunistic infections, unscheduled hospital stays, unscheduled lapses in treatment, hair loss, weight loss and secondary toxicity issues. He is currently a happy, healthy high school sophomore.

Dr. Clay plays an important role in our work in integrative medicine by providing unique knowledge from her regular practice. It differs in its style and greater efficacy than traditional with patients in a more supportive, less invasive practice of medicine.